Related content

Clinical Pharmacokinetics of Reboxetine, a Selective Norepinephrine Reuptake Inhibitor for the Treatment of Patients with Depression

By Fleishaker J.C.  

Clinical Pharmacokinetics, Vol. 39, Iss. 6, 2000-12 ,pp. : 413-427

Adis International

Access to resources Recommend Favorite

Asenapine Pharmacokinetics in Hepatic and Renal Impairment

By Peeters Pierre  

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 471-481

Adis International

Access to resources Recommend Favorite

Effect of hepatic or renal impairment on the pharmacokinetics of casopitant, a NK-1 receptor antagonist

By Bauman John  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 662-671

Springer Publishing Company

Access to resources Recommend Favorite

Antagonism of the stress-induced increase in cortical norepinephrine output by the selective norepinephrine reuptake inhibitor reboxetine

By Dazzi L.   Seu E.   Cherchi G.   Biggio G.  

European Journal of Pharmacology, Vol. 476, Iss. 1, 2003-08 ,pp. : 55-61

Elsevier

Access to resources Recommend Favorite

Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin

By Boulton David W.   Li Li   Frevert Ernst U.   Tang Angela   Castaneda Lorna   Vachharajani Nimish N.   Kornhauser David M.   Patel Chirag G.  

Clinical Pharmacokinetics, Vol. 50, Iss. 4, 2011-04 ,pp. : 253-265

Adis International

Access to resources Recommend Favorite